About 50mg Shilstine Leucovorin Calcium Injection
Experience an outstanding and premier choice in antidote therapy with the new Shilstine Leucovorin Calcium Injection 50mg. This scarce and extraordinary product offers a last chance solution as a rescue agent post-methotrexate treatment. Provided as a clear solution in a durable glass vial, Shilstine is suitable for intravenous or intramuscular administration in adults. With a precise 50 mg/5 ml dosage, this product is available by prescription only and stands out as a reliable adjunct for methotrexate therapy. Manufactured by Shilpa Medicare in India, this allopathic injection is a testament to excellence in pharmaceutical care.
Key Features and Indication
The 50mg Shilstine Leucovorin Calcium Injection is specifically designed for IV/IM use as directed by a physician. It serves as an essential rescue solution following high-dose methotrexate treatments, minimizing associated toxicities. With its superior glass vial packaging, clear solution appearance, and long shelf life of 24 months, Shilstine ensures both safety and practicality. It is ideal for adult patients requiring outstanding and timely therapeutic intervention.
Export Information and Offer Details
We are proud to offer Shilstine Leucovorin Calcium Injection 50mg to the global export market, supplied from India. FOB port shipment options are provided to ensure convenient outlay for international buyers. Payment terms can be flexibly arranged to facilitate seamless transactions, and a sample policy is available upon request. This offer ensures that importers, suppliers, and traders receive premier service and access to extraordinary products.
FAQ's of 50mg Shilstine Leucovorin Calcium Injection:
Q: How is Shilstine Leucovorin Calcium Injection administered?
A: Shilstine Leucovorin Calcium Injection is administered either intravenously (IV) or intramuscularly (IM), strictly as directed by a healthcare professional.
Q: What are the primary uses of this injection?
A: The injection is mainly used as an adjunct in methotrexate therapy and functions as a rescue medication to reduce the harmful effects of methotrexate toxicity.
Q: When should this injection be used?
A: Shilstine should be used following high-dose methotrexate treatment or as recommended by a physician to provide effective rescue therapy.
Q: Where is Shilstine Leucovorin Calcium Injection manufactured?
A: This product is manufactured in India by Shilpa Medicare, a well-regarded pharmaceutical company.
Q: What are the storage requirements for this injection?
A: The injection should be stored below 25C in a cool, dry place and kept in its original glass vial to ensure stability and potency.
Q: What benefits does Shilstine offer compared to other rescue agents?
A: Shilstine provides outstanding efficacy, a clear solution for accurate dosing, and reassurance of quality with a 24-month shelf life, packaged securely for global markets.